PharmaShots | Incisive News in 3 Shots

Subscribe Now

Reducing Stroke

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Priority Review for Reducing Stroke in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Priority Review for Reducing Stroke in Patients with Acute Ischemic Stro...

July 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us